|
1
|
Morrissey RP, Czer L and Shah PK: Chronic
heart failure. Wiley Handbook of Current and Emerging Drug
Therapies. Am J Cardiovasc Drugs. 11:153–171. 2006. View Article : Google Scholar
|
|
2
|
Hunt SA, Baker DW, Chin MH, Cinquegrani
MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G,
Jessup ML, et al American College of Cardiology/American Heart
Association, : ACC/AHA guidelines for the evaluation and management
of chronic heart failure in the adult: Executive summary. A report
of the American College of Cardiology/American Heart Association
Task Force on Practice Guidelines (Committee to revise the 1995
Guidelines for the Evaluation and Management of Heart Failure). J
Am Coll Cardiol. 38:2101–2113. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hunt SA, Abraham WT, Chin MH, Feldman AM,
Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K,
et al: ACC/AHA 2005 Guideline Update for the Diagnosis and
Management of Chronic Heart Failure in the Adult-Summary Article: A
Report of the American College of Cardiology/American Heart
Association Task Force on Practice Guidelines (Writing Committee to
Updat). J Am Coll Cardiol. 46:1116–1143. 2005. View Article : Google Scholar
|
|
4
|
Pocock SJ, Wang D, Pfeffer MA, Yusuf S,
McMurray JJ, Swedberg KB, Ostergren J, Michelson EL, Pieper KS and
Granger CB: Predictors of mortality and morbidity in patients with
chronic heart failure. Eur Heart J. 27:65–75. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hendry PB, Krisdinarti L and Erika M:
Scoring system based on electrocardiogram features to predict the
type of heart failure in patients with chronic heart failure.
Cardiol Res. 7:110–116. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Petrovic D: Cytopathological basis of
heart failure - cardiomyocyte apoptosis, interstitial fibrosis and
inflammatory cell response. Folia Biol (Praha). 50:58–62.
2004.PubMed/NCBI
|
|
7
|
Lepojärvi ES, Piira OP, Pääkkö E,
Lammentausta E, Risteli J, Miettinen JA, Perkiömäki JS, Huikuri HV
and Junttila MJ: Serum PINP, PIIINP, galectin-3, and ST2 as
surrogates of myocardial fibrosis and echocardiographic left
venticular diastolic filling properties. Front Physiol. 6:2002015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mukoyama M, Nakao K, Hosoda K, Suga S,
Saito Y, Ogawa Y, Shirakami G, Jougasaki M, Obata K and Yasue H:
Brain natriuretic peptide as a novel cardiac hormone in humans.
Evidence for an exquisite dual natriuretic peptide system, atrial
natriuretic peptide and brain natriuretic peptide. J Clin Invest.
87:1402–1412. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Anker SD, Coats AJ, Bonarjee VV, Caidahl
K, Lie RT, Nilsen DW, Sundsfjord JA and Dickstein K: Plasma brain
natriuretic peptide as an indicator of left ventricular systolic
function and long-term survival after acute myocardial infarction.
Circulation. 95:538–539. 1997.PubMed/NCBI
|
|
10
|
Nagaya N, Nishikimi T, Uematsu M, Satoh T,
Kyotani S, Sakamaki F, Kakishita M, Fukushima K, Okano Y, Nakanishi
N, et al: Plasma brain natriuretic peptide as a prognostic
indicator in patients with primary pulmonary hypertension. J
Cardiol. 37:110–111. 2001.(In Japanese). PubMed/NCBI
|
|
11
|
Degani R: Computerized electrocardiogram
diagnosis: Fuzzy approach. Methods Inf Med. 31:225–233. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nahler MPG: New York Heart Association
classification (NYHA). Dictionary of Pharmaceutical Medicine.
Springer; Vienna: pp. 121. 2009, View Article : Google Scholar
|
|
13
|
Wang Y, Xie B, Wan F, Xiao Q and Dai L:
Application of ROC curve analysis in evaluating the performance of
alien species potential distribution models. Biodiversity Sci.
15:365–372. 2007.(In Chinese). View Article : Google Scholar
|
|
14
|
Virk IS and Ip JR: The effect of cardiac
resynchronization on morbidity and mortality in heart failure.
Digest of the World Core Medical Journals 2005. https://doi.org/10.1111/j.1527-5299.2005.04176.xOctober
9–2008
|
|
15
|
Devereux RB and Reichek N:
Echocardiographic determination of left ventricular mass in man.
Anatomic validation of the method. Circulation. 55:613–618. 1977.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Droege ME, Mueller EW, Besl KM, Lemmink
JA, Kramer EA, Athota KP, Droege CA, Ernst NE, Keegan SP, Lutomski
DM, et al: Effect of a dalteparin prophylaxis protocol using
anti-factor Xa concentrations on venous thromboembolism in
high-risk trauma patients. J Trauma Acute Care Surg. 76:450–456.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Moe GW: BNP in the diagnosis and risk
stratification of heart failure. Heart Fail Monit. 4:116–122.
2005.PubMed/NCBI
|
|
18
|
Aldamiz-Echevarría Iraúrgui B, Muñiz J,
Rodríguez-Fernández JA, Vidán-Martínez L, Silva-César M,
Lamelo-Alfonsín F, Díaz-Díaz JL, Ramos-Polledo V and Castro-Beiras
A: Randomized controlled clinical trial of a home care unit
intervention to reduce readmission and death rates in patients
discharged from hospital following admission for heart failure. Rev
Esp Cardiol. 60:914–922. 2007.(In Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yonezawa E, Matsumoto K, Ueno K, Tachibana
M, Hashimoto H, Komamura K, Kamakura S, Miyatake K and Tanaka K:
Lack of interaction between amiodarone and mexiletine in cardiac
arrhythmia patients. J Clin Pharmacol. 42:342–346. 2002. View Article : Google Scholar : PubMed/NCBI
|
